je.st
news
Tag: hansa
Hansa Medical receives FDA Orphan Drug Designation for IdeS
2015-09-15 06:06:51| Appliances - Topix.net
Hansa Medical today announced that the U.S. Food and Drug Administration has granted orphan drug designation to IdeS for the prevention of antibody mediated organ rejection in solid organ transplant patients. More information about the ODD has been posted on www.fda.com Approximately 30 percent of the patients on the waiting lists for kidney, heart, lung and pancreas, equivalent to approximately 35 000 patients in the US, are sensitized to Human Leukocyte Antigen .
Tags: medical
drug
receives
designation
Hansa Medical develops second-generation IdeS molecules for repeat dosing
2015-02-12 14:11:05| Appliances - Topix.net
Hansa Medical AB announced today that the company is developing a new generation of molecules based on IdeS that will allow repeat dosing and thereby broadening the therapeutic opportunities into more chronic disease areas. Since IdeS is a bacterial protein from Group A streptococcus the human immune system recognizes IdeS as foreign and reacts against the molecule.
Tags: medical
repeat
develops
molecules
Hansa Medical nomination committee for the Annual General Meeting 2015 has been established
2015-02-03 20:30:35| Appliances - Topix.net
The Chairman of the Board of Directors of Hansa Medical AB has convened a nomination committee. The nomination committee's intention is to submit proposals to the Annual General Meeting mainly in accordance with the requirements stipulated in the Swedish Corporate Governance Code.
Tags: general
medical
established
meeting
Hansa Medical financial reporting dates
2015-01-15 17:33:35| Appliances - Topix.net
Hansa Medical proceeds to releasing financial reports quarterly. The following dates have been scheduled for financial reporting during 2015: Year-end release 2014, February 13, 2015 Annual report 2014, March 2, 2015 Interim report January - March 2015, April 16, 2015 Annual General Meeting 2015, April 16, 2015 Interim report January - June 2015, August 25, 2015 Interim report January - September 2015, October 28, 2015 For further information, please contact: Hansa Medical AB Fredrik Lindgren, President and CEO Mobile: 46 705 61 61 77 E-mail: fredrik.lindgren@hansamedical.com www.hansamedical.com About Hansa Medical AB Hansa Medical is a biopharmaceutical company focused on novel immunomodulatory enzymes.
Tags: medical
financial
dates
reporting
Sites : [1] [2]